A Phase III, Prospective, Randomized, Double-Blind Trial of Valganciclovir Pre-Emptive Therapy for Cytomegalovirus (CMV) Viremia as Detected by Plasma CMV DNA PCR Assay.
Phase of Trial: Phase III
Latest Information Update: 08 Jul 2013
At a glance
- Drugs Valganciclovir (Primary)
- Indications Colitis; Cytomegalovirus retinitis; End-organ damage; Pancreatitis
- Focus Therapeutic Use
- 12 Oct 2005 New trial record.